INTU vs MRK: Which Is the Better Buy?
Side-by-side comparison of Intuit Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Intuit Inc. · Technology
$277.13
+25.3% upside to fair value
Med Conviction
Grade B
High Quality
VS
Merck & Co., Inc. · Healthcare
$147.17
-4.1% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
INTU has more upside to fair value
(+25.3%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
INTU |
MRK |
| Current Price |
$277.13 |
$147.17 |
| Fair Value Estimate |
$347.25 |
$141.07 |
| Upside to Fair Value |
+25.3%
|
-4.1%
|
| Market Cap |
$75.8B |
$363.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
11.0x
|
29.6x
|
| Price / Sales |
3.5x
|
5.5x
|
| Price / FCF |
8.8x
|
22.6x
|
| Revenue Growth YoY |
+13.7%
|
+5.1%
|
| Gross Margin |
80.9%
|
75.4%
|
| Operating Margin |
28.8%
|
16.7%
|
| Return on Equity |
23.4%
|
6.6%
|
| Dividend Yield |
1.73% |
2.31% |
| FCF Yield |
11.43%
|
4.42%
|
| Analyst Consensus |
Buy
|
Buy
|
Investment Thesis
Intuit is a financial management software platform serving small and mid-market businesses through QuickBooks, consumers through TurboTax, and consumers through Credit Karma, with a professional tax segment in Lacerte, ProSeries and ProConnect. The business quality is high on fundamentals: TTM gross margin of 80.9%, TTM operating margin of 28.8%, TTM net margin of 21.3%, ROE of 23.4%, and free ca…
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
Accumulation Zones
| Metric |
INTU |
MRK |
| Zone Low |
$260.44 |
$105.80 |
| Zone High |
$295.16 |
$119.91 |
| In Buy Zone? |
Yes
|
No
|